Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
about
The search for novel analgesics: targets and mechanismsChemotherapy-induced peripheral neuropathy: an update on the current understandingInterleukin-6: an emerging regulator of pathological painMechanisms of chemotherapy-induced behavioral toxicitiesCross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study.AAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewIdentifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics TechnologyChemotherapy-induced neuropathies-a growing problem for patients and health care providersPaclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral NeuropathyInhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy.CXCR1/2 pathways in paclitaxel-induced neuropathic painDisease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic.Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy.Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis.Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsCD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.Preventative and therapeutic effects of a GABA transporter 1 inhibitor administered systemically in a mouse model of paclitaxel-induced neuropathic pain.A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercisesChallenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage.Genetics of chronic post-surgical pain: a crucial step toward personal pain medicine.Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Evaluation of inter-batch differences in stem-cell derived neurons.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat.Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer.Update on Chemotherapy-Induced Peripheral Neuropathy.Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis.
P2860
Q24288817-FB0AB1C6-B7B0-4334-A8A7-08A1DCEEAF15Q26740689-B5788491-71DA-4A93-B878-DBD3086FA0A1Q26748646-7FF5B954-92A6-4395-84B6-1B89492056DCQ26998870-4AD040FA-5B84-4CFB-AAD7-29284CC47DE0Q27316125-E4FBD992-608E-4A7F-8C9E-ABB21EE4C29FQ28079708-D110F78B-AA39-44DE-96B1-F5E268C447EBQ28270819-D2A02D39-020E-41D9-B268-398B731AEFAAQ28551798-B1C7BCE9-2F15-4315-98F3-91EF5519EBAAQ28818565-AE94A2B6-9286-497C-9C37-97FEDB94D8F4Q30491771-74846AB4-4675-4F30-92EA-16BF93EB9D5BQ33552212-ECECCE80-72DA-4A36-8408-25088482EEEAQ33571709-FCB919B4-60EC-4755-80AF-E12A733B1FC7Q33618624-28DA1348-E6DE-4A56-950B-5C5B3375E607Q33711656-639620C6-4B43-4A27-9641-3AD2A79DCDD7Q33744706-4511224D-D6F7-4A6C-B128-2DD49CE287F5Q33796889-6254E8B0-4F2A-4052-8356-F055EE5D7EBDQ33824948-4C3F5EB1-F91C-4495-A659-BA613499CF30Q35659204-E7335ADE-F57D-4FBE-BD23-8A86F07779D4Q35898310-F3D5399D-7F42-4F43-959B-02F685AFF58CQ36132137-BF655F70-D5C2-40AE-BEC2-24EF2074F8DFQ36245963-CE6E12D9-8B01-4D65-BC3B-845B7D94852AQ36261283-AB535A6E-D2E3-4977-AB5A-F091605634E9Q36321725-B7B36284-CE02-4717-9B9B-47C4F71C5F62Q36702996-9D39FE17-FD6E-4367-A72E-B6705C8E3482Q36770149-851F8723-75A3-4198-949E-E3DAC707530AQ37170634-79816A8D-BCF5-497D-81BB-CDDD6C5F86DFQ37398478-58384FFE-A7FE-4A65-B506-9E2CA650B008Q37510955-FB13582C-39C5-4427-B9C6-DA490CD0C7BBQ37631063-952DD818-8EBF-47EF-8726-1A39B88E5D56Q37655675-36509180-F129-48C2-8297-AF12029CB95AQ38282574-824774BC-691E-49A6-983C-CF01EE714F27Q38426849-DCD62274-6A47-4A8C-81D4-413018B2BB0EQ38522262-B0908F3F-8F20-4F3A-9FE3-D95032E2BC6EQ38589233-FBB18217-6A8F-4785-8F7A-77C3961507E5Q38600704-F7D5F587-D217-4A10-9F88-AED4BD77F168Q38664595-0301F023-7A63-4965-8E32-BAB7C14D69CBQ38694326-436BE68C-E79E-4264-ADB6-C5994C13C0C7Q38716338-18ECEAB5-B168-4ED6-94B7-1B7F178B9C59Q38728572-098ADA25-EFBC-4A5D-9D16-96D81B0AB445Q38730768-195F6FDC-8127-4F78-8771-A0BA425AED54
P2860
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Incidence, prevalence, and pre ...... matic review and meta-analysis
@ast
Incidence, prevalence, and pre ...... matic review and meta-analysis
@en
Incidence, prevalence, and pre ...... matic review and meta-analysis
@nl
type
label
Incidence, prevalence, and pre ...... matic review and meta-analysis
@ast
Incidence, prevalence, and pre ...... matic review and meta-analysis
@en
Incidence, prevalence, and pre ...... matic review and meta-analysis
@nl
prefLabel
Incidence, prevalence, and pre ...... matic review and meta-analysis
@ast
Incidence, prevalence, and pre ...... matic review and meta-analysis
@en
Incidence, prevalence, and pre ...... matic review and meta-analysis
@nl
P2093
P31
P50
P3181
P1433
P1476
Incidence, prevalence, and pre ...... matic review and meta-analysis
@en
P2093
Gillian L Currie
Marta Seretny
Robin Grant
Sabrina Ramnarine
P304
P3181
P356
10.1016/J.PAIN.2014.09.020
P407
P577
2014-12-01T00:00:00Z